Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Family Depression Prevention Program (FDP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02021578
Recruitment Status : Recruiting
First Posted : December 27, 2013
Last Update Posted : February 6, 2020
Sponsor:
Collaborator:
San Diego State University
Information provided by (Responsible Party):
Judith Garber, Vanderbilt University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

The primary aim is to prevent depression in youth and parents in a single, integrated family intervention.

Hypothesis 1a: Children in the Family Depression Prevention (FDP) program will have significantly fewer onsets of depressive episodes and lower levels of anxious/depressive symptoms as compared to children in the Written Information (WI) condition.

Hypothesis 1b: In parents, the amount of time in a depressive episode will be significantly lower for those in the FDP program as compared to those in the WI condition.


Condition or disease Intervention/treatment Phase
Depression Behavioral: Family Cognitive Behavioral Prevention Behavioral: Written information Not Applicable

Detailed Description:
Depression is a major public health problem affecting over 15 million U.S. adults annually and is especially prevalent in those of parenting age. Offspring of depressed parents are at increased risk of depression and therefore are a critical target for preventive interventions. The current study aims to reduce the rate of depression in parents and their children by adopting an innovative, family-based approach to simultaneously preventing depression in at-risk youth and in their affected parents. The rationale for this approach is based on (a) a conceptual model that integrates parenting processes, stress (particularly that which is associated with parental depression), and children's self-regulatory skills in the face of stress, (b) evidence that depression runs in families, (c) promising results from family- and child-focused depression prevention programs, (d) evidence that in adults, cognitive-behavioral therapy (CBT) reduces both depressive episodes and their recurrence, and (e) growing consensus among scientists, clinicians, and policymakers on the need for family-based models of healthcare. This 5- year, two-site randomized controlled trial will test a Family Depression Prevention (FDP) program for children (ages 9-15) and their parents with depressive disorders (past or current). This "dual prevention" approach is a novel synthesis of existing evidence-based intervention techniques drawn from child prevention and adult treatment models. Participating families (N=300) will be randomized to either FDP (12 weekly + 3 monthly sessions) or a written information comparison (WI) condition. All parents and children will be evaluated at pre- and post-intervention, and at 6-, 12-, 18-, and 24-months from baseline.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 300 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Family Cognitive Behavioral Prevention of Depression in Youth and Parents
Study Start Date : December 2014
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Family Cognitive Behavioral Prevention
A family cognitive behavioral program for parents and children. Parents learn parenting skills and cognitive behavioral techniques for managing depression. Children learn coping skills.
 Behavioral: Family Cognitive Behavioral Prevention
Parent training and cognitive behavioral intervention with parents. Coping skills training with children.
Other Names:
  • Cognitive behavioral intervention
  • Coping skills training
  • Parent training
Active Comparator: Written Information
Families receive written materials about depression and the effects of parental depression on children.
 Behavioral: Written information
Reading materials about depression
Other Names:
  • Psychoeducation
  • Self-help


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. In children, the primary outcome is onset of a depressive episode. In parents, the primary outcome is time in a depressive episode. [ Time Frame: up to two years ]

    For child participants, we will assess time to onset of a depressive disorder (e.g., Major Depressive Episode; persistent depressive disorder) using a semi-structured clinical interview, the Longitudinal Interval Follow-up Evaluation (LIFE).

    For parent participants, we also will use the LIFE to measure the amount of time in a depressive episode during the assessment interval.



Secondary Outcome Measures :
  1. Parents: Patient Health Questionnaire - 9 (PHQ-9) [ Time Frame: past two weeks ]
    Parent participants: The PHQ-9 measures 9 symptoms of depression on a 4-point scale. Scores can range from 0 to 36.

  2. Children: Youth Self-report (YSR) anxiety/depression subscale [ Time Frame: six months ]
    Children will complete the YSR, which is a self-report checklist containing 112 items scored on a 3-point scale.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   9 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Parent with a current or history of a depressive disorder within child's life
  • Children ages 9.0 to 15.6 years old

Exclusion Criteria:

  • Bipolar I (parent or child)
  • Schizophrenia (parent or child)
  • Current alcohol or drug abuse (parent or child)
  • Conduct disorder; developmental disability (child)
  • Current diagnosis of a depressive disorder (child)
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02021578


Locations
Layout table for location information
United States, California
San Diego State University Recruiting
San Diego, California, United States, 92120-4913
Contact: Robin Weersing, PhD    619-594-8892    robin.weersing@mail.sdsu.edu   
Principal Investigator: Robin Weersing, PhD         
United States, Tennessee
Vanderbilt University Recruiting
Nashville, Tennessee, United States, 37203-5721
Contact: Judy Garber, PhD    615-343-0595    jgarber.vanderbilt@gmail.com   
Contact: Bruce Compas, PhD    615-322-8306    Bruce.Compas@Vanderbilt.edu   
Principal Investigator: Judy Garber, PhD         
Principal Investigator: Bruce Compas, PhD         
Sponsors and Collaborators
Vanderbilt University
San Diego State University
Investigators
Layout table for investigator information
Principal Investigator: Judy Garber, PhD Vanderbilt University
Principal Investigator: Bruce Compas, PhD Vanderbilt University
Principal Investigator: Robin Weersing, PhD San Diego State University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
Responsible Party: Judith Garber, Professor, Vanderbilt University
ClinicalTrials.gov Identifier: NCT02021578    
Other Study ID Numbers: 8482529
First Posted: December 27, 2013    Key Record Dates
Last Update Posted: February 6, 2020
Last Verified: February 2020
Keywords provided by Judith Garber, Vanderbilt University:
Depression
Mood disorder
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders